Literature DB >> 26585568

Rapidly growing giant cell tumor of bone in a skeletally immature girl.

Gensuke Akaike1,2, Teruko Ueno3, Seiichi Matsumoto4, Noriko Motoi5,6, Kiyoshi Matsueda3.   

Abstract

Giant cell tumor of bone (GCTB) in skeletally immature patients is rare, and little is known regarding how fast GCTB can grow. We report a case of a 10-year-old skeletally immature girl with pathologically proven GCTB with obvious growth plate invasion that showed surprisingly rapid growth over only 14 days. A radiograph of the left knee revealed well-circumscribed, geographic bone destruction at the distal metaphysis of the femur with a focal cortical defect, suggesting a pathologic fracture. No abnormal mineralization or periosteal reaction was seen. A CT without contrast and an MRI demonstrated a homogeneous lesion with cortical disruption posteriorly and laterally with a slight soft tissue extension. Biopsy showed numerous multinucleated giant cells and spindle-shaped mononuclear cells without any sign of malignancy, suggesting GCTB. However, rapid lesion enlargement and destruction of the surrounding cortex were noted 14 days after biopsy. Considering the amount of bone destruction, traditional treatment of curettage and bone cement would not suffice to sustain structural strength. In addition, considering the patient's age, the tumor location, and the aggressive course, a malignant tumor, especially a giant cell-rich osteosarcoma, could not be excluded. Therefore, en bloc resection, including the growth plate and prosthetic replacement, were performed. Confirmation of GCTB was made from a pathologic evaluation, and a breach to the growth plate was identified. Since very little inflammatory reaction, degenerative change, or aneurysmal, bone, cyst-like change was found, the growth plate invasion was confirmed as due to GCTB extension, not due to the preoperative biopsy.

Entities:  

Keywords:  Epiphyseal plate; GCT; Giant cell tumor of bone; Growth plate; Skeletally immature

Mesh:

Year:  2015        PMID: 26585568     DOI: 10.1007/s00256-015-2276-4

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  16 in total

1.  Management of grade III giant cell tumors of bones.

Authors:  Hsien-Chung Wang; Song-Hsiung Chien; Gau-Tyan Lin
Journal:  J Surg Oncol       Date:  2005-10-01       Impact factor: 3.454

2.  Morphological studies on the resistance of cartilage to invasion by osteosarcoma cells in vitro and in vivo.

Authors:  K E Kuettner; B U Pauli; L Soble
Journal:  Cancer Res       Date:  1978-02       Impact factor: 12.701

3.  Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.

Authors:  David Thomas; Robert Henshaw; Keith Skubitz; Sant Chawla; Arthur Staddon; Jean-Yves Blay; Martine Roudier; Judy Smith; Zhishen Ye; Winnie Sohn; Roger Dansey; Susie Jun
Journal:  Lancet Oncol       Date:  2010-02-10       Impact factor: 41.316

4.  Giant-cell tumor of bone in skeletally immature patients.

Authors:  P Picci; M Manfrini; V Zucchi; F Gherlinzoni; M Rock; F Bertoni; J R Neff
Journal:  J Bone Joint Surg Am       Date:  1983-04       Impact factor: 5.284

5.  Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.

Authors:  Daniel G Branstetter; Scott D Nelson; J Carlos Manivel; Jean-Yves Blay; Sant Chawla; David M Thomas; Susie Jun; Ira Jacobs
Journal:  Clin Cancer Res       Date:  2012-06-18       Impact factor: 12.531

6.  Giant cell tumor in skeletally immature patients.

Authors:  M J Kransdorf; D E Sweet; P C Buetow; M A Giudici; R P Moser
Journal:  Radiology       Date:  1992-07       Impact factor: 11.105

7.  Giant cell tumor of bone in children and adolescents.

Authors:  Ajay Puri; Manish G Agarwal; Mandip Shah; Nirmala A Jambhekar; Chetan Anchan; Sanica Behle
Journal:  J Pediatr Orthop       Date:  2007-09       Impact factor: 2.324

Review 8.  Giant cell tumor of bone: review, mimics, and new developments in treatment.

Authors:  Corey J Chakarun; Deborah M Forrester; Christopher J Gottsegen; Dakshesh B Patel; Eric A White; George R Matcuk
Journal:  Radiographics       Date:  2013 Jan-Feb       Impact factor: 5.333

9.  Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study.

Authors:  Sant Chawla; Robert Henshaw; Leanne Seeger; Edwin Choy; Jean-Yves Blay; Stefano Ferrari; Judith Kroep; Robert Grimer; Peter Reichardt; Piotr Rutkowski; Scott Schuetze; Keith Skubitz; Arthur Staddon; David Thomas; Yi Qian; Ira Jacobs
Journal:  Lancet Oncol       Date:  2013-07-16       Impact factor: 41.316

10.  Multicentric giant cell tumor of bone.

Authors:  C A Cummins; M T Scarborough; W F Enneking
Journal:  Clin Orthop Relat Res       Date:  1996-01       Impact factor: 4.176

View more
  1 in total

1.  Giant Cell Tumor of Bone: Documented Progression over 4 Years from Its Origin at the Metaphysis to the Articular Surface.

Authors:  Colin Burke; Thomas Link; Richard J O'Donnell; Soo-Jin Cho; Daria Motamedi
Journal:  Case Rep Radiol       Date:  2016-08-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.